| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Caladrius Biosciences Inc (NASDAQ: CLBS)
CLBS Technical Analysis
5
| As on 7th Oct 2022 CLBS STOCK Price closed @ 4.54 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.15 & Strong Buy for SHORT-TERM with Stoploss of 1.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CLBSSTOCK Price
| Open | 4.85 | Change | Price | % |
| High | 5.16 | 1 Day | -0.33 | -6.78 |
| Low | 4.54 | 1 Week | 0.13 | 2.95 |
| Close | 4.54 | 1 Month | 4.02 | 773.08 |
| Volume | 21051 | 1 Year | 2.91 | 178.53 |
| 52 Week High 7.66 | 52 Week Low 0.41 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CLBS Daily Charts |
CLBS Intraday Charts |
Whats New @ Bazaartrend |
CLBS Free Analysis |
|
|
CLBS Important Levels Intraday
| RESISTANCE | 5.73 |
| RESISTANCE | 5.35 |
| RESISTANCE | 5.11 |
| RESISTANCE | 4.88 |
| SUPPORT | 4.20 |
| SUPPORT | 3.97 |
| SUPPORT | 3.73 |
| SUPPORT | 3.35 |
CLBS Forecast May 2024
| 4th UP Forecast | 5.21 |
| 3rd UP Forecast | 5 |
| 2nd UP Forecast | 4.86 |
| 1st UP Forecast | 4.73 |
| 1st DOWN Forecast | 4.35 |
| 2nd DOWN Forecast | 4.22 |
| 3rd DOWN Forecast | 4.08 |
| 4th DOWN Forecast | 3.87 |
CLBS Weekly Forecast
| 4th UP Forecast | 4.96 |
| 3rd UP Forecast | 4.83 |
| 2nd UP Forecast | 4.74 |
| 1st UP Forecast | 4.66 |
| 1st DOWN Forecast | 4.42 |
| 2nd DOWN Forecast | 4.34 |
| 3rd DOWN Forecast | 4.25 |
| 4th DOWN Forecast | 4.12 |
CLBS Forecast2024
| 4th UP Forecast | 22.56 |
| 3rd UP Forecast | 16.78 |
| 2nd UP Forecast | 13.21 |
| 1st UP Forecast | 9.64 |
| 1st DOWN Forecast | -0.56 |
| 2nd DOWN Forecast | -4.13 |
| 3rd DOWN Forecast | -7.7 |
| 4th DOWN Forecast | -13.48 |
Caladrius Biosciences Inc ( NASDAQ USA Symbol : CLBS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CLBS Business Profile
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service